Viewing data from:

VALRUBICIN

ANDA

VALRUBICIN | A206430 | HIKMA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: VALSTAR PRESERVATIVE FREE(TE code: AO)

Medicare Part B Spending

CMS physician-administered drug spending for Valrubicin (2023)

Total Spending

$1.9M

Total Claims

380

Beneficiaries

ASP Price

—

HCPCS: J9357 — Injection, valrubicin, intravesical, 200 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVVALRUBICIN (AD-32)

DMF 124051997

SYNBIAS PHARMA AGVALRUBICIN USP

DMF 269182013

DZD (HEZE) PHARMACEUTICAL CO LTDVALRUBICIN

DMF 345212020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 40MG/ML

0 patents0 exclusivities▴

SOLUTION;INTRAVESICAL | Approved: Apr 19, 2019

No patent or exclusivity listings for this strength.